Skip to main content
. 2015 Feb 4;6(6):4496–4504. doi: 10.18632/oncotarget.2883

Table 3. Serum mesothelin and CA125 before and after 111In-amatuximab.

Patient Age/Sex Diagnosis Mesothelin Levels (nMol/L)* CA125 (U/mL)^
Baseline Day 14 Baseline Day 14
001 71/F Mesothelioma 4.4 6.0 86.3 188
002 53/M Mesothelioma 11.8 15.4 1205 1447
003 62/M Mesothelioma 3.8 5.8 5.8 9.1
004 70/M Mesothelioma 9.6 14.8 5.4 15.0
005 54/M Pancreatic adenocarcinoma 0.6 0.5 52 143
007 73/F Pancreatic adenocarcinoma 0.6 0 466 1165
*

≥ 1.5 nMol/L is considered abnormally high

^

Normal range is 1.9–16.3 U/ml